Literature DB >> 26547126

Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.

Junbao Wei1, Su Pei1, Xiaodong Zhu2.   

Abstract

The objective of this study was to assess the overall diagnostic value of MRI, SPECT and 18F-FDG PET/CT in detecting local NPC residual/recurrence with a meta-analysis. We performed a systematic review with meta-analyses to compare the diagnostic performance of nuclear magnetic resonance Imaging (MRI), single photon emission computed tomography (SPECT) and 18-fluoro-2-deoxyglucose positron emission tomography (18F-FDG PET/CT) as imaging modalities for the detection of local residual or recurrent nasopharyngeal carcinoma (NPC). MEDLINE, EMBASE and publisher databases were searched in December 2014. Methodological quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tool. Pooled estimation and subgroup analysis data were obtained by statistical analysis. Seventeen studies were included in the meta-analysis. The pooled sensitivity estimates for 18F-FDGPET/CT (90%) and SPECT (85%) were not significantly higher than MRI (77%) (p=0.096 and 0.164, respectively). The pooled specificity estimates for 18F-FDGPET/CT (93%) and SPECT (81%) were significantly higher than MRI (76%) (p=0.033 and 0.042, respectively). The pooled DOR (Diagnostic odds ratio) estimates for 18F-FDGPET/CT (73.27) were significantly higher than MRI (12.09) (p=0.019) while the pooled DOR estimates for SPECT (78.69) were not significantly higher than MRI (12.09) (p=0.872). For 18F-FDGPET/CT, there were no significant differences between PET-CT and PET on all of the variables including sensitivity, specificity, PLR (Positive likelihood ratio), NLR (Negative likelihood ratio) and DOR (P>0.05). For SPECT, there were no significant differences between 201TI-SPECT and MIBI-SPECT on all of the variables including sensitivity, specificity, PLR, NLR and DOR (P>0.05). Both 18F-FDGPET/CT and SPECT are very accurate for the detection of local residual or recurrent NPC, they are superior to MRI in distinguishing recurrent NPC from fibrosis or scar tissue after RT in irradiated fields with distortion of normal architecture. For 18F-FDGPET/CT, the diagnostic accuracy PET/CT was not significantly different than that of PET alone. For SPECT, 201TI-SPECT and MIBI-SPECT have the same diagnostic accuracy.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (18)F-FDGPET/CT; Local residual/recurrent; MRI; Meta-analysis; Nasopharyngeal carcinoma; SPECT

Mesh:

Substances:

Year:  2015        PMID: 26547126     DOI: 10.1016/j.oraloncology.2015.10.010

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  14 in total

Review 1.  The evolution of nasopharyngeal carcinoma staging.

Authors:  Rui Guo; Yan-Ping Mao; Ling-Long Tang; Lei Chen; Ying Sun; Jun Ma
Journal:  Br J Radiol       Date:  2019-07-12       Impact factor: 3.039

2.  Effects of Surgery Combined with Chemoradiotherapy on Short- and Long-Term Outcomes of Early-Stage Nasopharyngeal Carcinoma.

Authors:  Jing-Jin Weng; Jia-Zhang Wei; Min Li; Shao-Jie Zhang; Yun-Zhong Wei; Han-Wei Wang; Dan-Xue Qin; Jin-Long Lu; He Jiang; Shen-Hong Qu
Journal:  Cancer Manag Res       Date:  2020-08-25       Impact factor: 3.989

3.  Long-term outcomes and safety after reirradiation in locally recurrent nasopharyngeal carcinoma in a non-endemic area.

Authors:  J Boustani; A Ruffier; A Moya-Plana; Y Tao; F Nguyen; C Even; C Berthold; O Casiraghi; S Temam; P Blanchard
Journal:  Strahlenther Onkol       Date:  2020-06-08       Impact factor: 3.621

Review 4.  Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.

Authors:  Yecai Huang; Mei Feng; Qiao He; Jun Yin; Peng Xu; Qinghua Jiang; Jinyi Lang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

5.  Positron emission tomography/computed tomography outperforms MRI in the diagnosis of local recurrence and residue of nasopharyngeal carcinoma: An update evidence from 44 studies.

Authors:  Zhanzhan Li; Yanyan Li; Na Li; Liangfang Shen
Journal:  Cancer Med       Date:  2018-12-21       Impact factor: 4.452

6.  Hopkins criteria for residual disease assessment after definitive radiotherapy in nasopharyngeal carcinoma.

Authors:  Yang Liu; Wen Long; Guannan Wang; Yuxiang Yang; Biaoshui Liu; Wei Fan
Journal:  Cancer Med       Date:  2019-12-25       Impact factor: 4.452

7.  SEOM-TTCC clinical guideline in nasopharynx cancer (2021).

Authors:  Antonio Rueda Domínguez; Beatriz Cirauqui; Almudena García Castaño; Ruth Alvarez Cabellos; Alberto Carral Maseda; Beatriz Castelo Fernández; Leticia Iglesias Rey; Jordi Rubió-Casadevall; Virginia Arrazubi; Ricard Mesía
Journal:  Clin Transl Oncol       Date:  2022-03-18       Impact factor: 3.405

8.  18F-Fluorodeoxyglucose-positron Emission Tomography/Computed Tomography Imaging of Metastatic Nasopharyngeal Cancer with Emphasis on the Distribution of Bone Metastases.

Authors:  Ammad Shanoon Al Tamimi; Sumbul Zaheer; David Chee Ng; Saabry Osmany
Journal:  World J Nucl Med       Date:  2017 Jul-Sep

Review 9.  18F-FDG PET with or without CT in the diagnosis of extrahepatic metastases or local residual/recurrent hepatocellular carcinoma.

Authors:  Xiaoli Liao; Junbao Wei; Yongqiang Li; Jianhong Zhong; Zhihui Liu; Sina Liao; Qian Li; Changyuan Wei
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

10.  Clinical significance of the post-radiotherapy 18F-fludeoxyglucose positron emission tomography response in nasopharyngeal carcinoma.

Authors:  Yuri Jeong; In-Hye Jung; Jae Seung Kim; Sei Kyung Chang; Sang-Wook Lee
Journal:  Br J Radiol       Date:  2019-01-03       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.